Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-7-25
pubmed:abstractText
To compare the safety and intraocular pressure (IOP)-lowering efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution (Trav/Tim) to its components travoprost 0.004% ophthalmic solution, TRAVATAN, (Trav) and timolol 0.5% ophthalmic solution (Tim) in patients with open-angle glaucoma or ocular hypertension.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0002-9394
pubmed:author
pubmed:issnType
Print
pubmed:volume
140
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15990081-Adult, pubmed-meshheading:15990081-Aged, pubmed-meshheading:15990081-Aged, 80 and over, pubmed-meshheading:15990081-Antihypertensive Agents, pubmed-meshheading:15990081-Blood Pressure, pubmed-meshheading:15990081-Cloprostenol, pubmed-meshheading:15990081-Double-Blind Method, pubmed-meshheading:15990081-Drug Combinations, pubmed-meshheading:15990081-Female, pubmed-meshheading:15990081-Glaucoma, Open-Angle, pubmed-meshheading:15990081-Heart Rate, pubmed-meshheading:15990081-Humans, pubmed-meshheading:15990081-Intraocular Pressure, pubmed-meshheading:15990081-Male, pubmed-meshheading:15990081-Middle Aged, pubmed-meshheading:15990081-Ocular Hypertension, pubmed-meshheading:15990081-Ophthalmic Solutions, pubmed-meshheading:15990081-Safety, pubmed-meshheading:15990081-Timolol, pubmed-meshheading:15990081-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
pubmed:affiliation
University of Washington, Ophthalmology, Specialty Eye Care Center, Seattle, 98004, USA. h.barnebey@verizon.net
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study